These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 27007745)
21. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038 [TBL] [Abstract][Full Text] [Related]
22. Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: preformulation and pharmacodynamic evaluation. Bahadur S; Pathak K Curr Drug Deliv; 2012 Nov; 9(6):596-607. PubMed ID: 22788695 [TBL] [Abstract][Full Text] [Related]
23. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies. Parikh RH; Patel RJ Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977 [TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. Jain R; Patravale VB J Biomed Nanotechnol; 2009 Feb; 5(1):62-8. PubMed ID: 20055107 [TBL] [Abstract][Full Text] [Related]
25. Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Beg S; Jena SS; Patra ChN; Rizwan M; Swain S; Sruti J; Rao ME; Singh B Colloids Surf B Biointerfaces; 2013 Jan; 101():414-23. PubMed ID: 23010049 [TBL] [Abstract][Full Text] [Related]
26. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Hosny KM; Banjar ZM Expert Opin Drug Deliv; 2013 Aug; 10(8):1033-41. PubMed ID: 23795561 [TBL] [Abstract][Full Text] [Related]
27. Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Pandey YR; Kumar S; Gupta BK; Ali J; Baboota S Nanotechnology; 2016 Jan; 27(2):025102. PubMed ID: 26629830 [TBL] [Abstract][Full Text] [Related]
29. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions. Djekic L; Primorac M; Filipic S; Agbaba D Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578 [TBL] [Abstract][Full Text] [Related]
30. Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug. Bandivadeka MM; Pancholi SS; Kaul-Ghanekar R; Choudhari A; Koppikar S Drug Dev Ind Pharm; 2012 Jul; 38(7):883-92. PubMed ID: 22087760 [TBL] [Abstract][Full Text] [Related]
31. Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Yoo JH; Shanmugam S; Thapa P; Lee ES; Balakrishnan P; Baskaran R; Yoon SK; Choi HG; Yong CS; Yoo BK; Han K Arch Pharm Res; 2010 Mar; 33(3):417-26. PubMed ID: 20361307 [TBL] [Abstract][Full Text] [Related]
32. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B. Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145 [TBL] [Abstract][Full Text] [Related]
33. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies. Kumar D; Ali J; Baboota S Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633 [TBL] [Abstract][Full Text] [Related]
34. Intranasal Tadalafil nanoemulsions: formulation, characterization and pharmacodynamic evaluation. Elbardisy B; Galal S; Abdelmonsif DA; Boraie N Pharm Dev Technol; 2019 Nov; 24(9):1083-1094. PubMed ID: 31215307 [TBL] [Abstract][Full Text] [Related]
35. Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro. Colombo M; Figueiró F; de Fraga Dias A; Teixeira HF; Battastini AMO; Koester LS Int J Pharm; 2018 May; 543(1-2):214-223. PubMed ID: 29605695 [TBL] [Abstract][Full Text] [Related]
36. Permeation and skin retention of quercetin from microemulsions containing Transcutol® P. Censi R; Martena V; Hoti E; Malaj L; Di Martino P Drug Dev Ind Pharm; 2012 Sep; 38(9):1128-33. PubMed ID: 22188183 [TBL] [Abstract][Full Text] [Related]
37. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress. Pangeni R; Sharma S; Mustafa G; Ali J; Baboota S Nanotechnology; 2014 Dec; 25(48):485102. PubMed ID: 25392203 [TBL] [Abstract][Full Text] [Related]
38. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. Shen H; Zhong M J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176 [TBL] [Abstract][Full Text] [Related]
39. Lipid based nanoemulsifying resveratrol for improved physicochemical characteristics, in vitro cytotoxicity and in vivo antiangiogenic efficacy. Pund S; Thakur R; More U; Joshi A Colloids Surf B Biointerfaces; 2014 Aug; 120():110-7. PubMed ID: 24905685 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the versatile character of a nanoemulsion formulation. Gué E; Since M; Ropars S; Herbinet R; Le Pluart L; Malzert-Fréon A Int J Pharm; 2016 Feb; 498(1-2):49-65. PubMed ID: 26685727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]